Plaintiff

TradeStation Technologies, Inc.

3 cases as plaintiff.

Cases
3
Active
0
3 closed
Filed
2016
Top venue
PTAB
1 case
Also appears as a defendant in 1 case → View as defendant

Company profile

I'll research TradeStation to verify its profile.

Let me verify the ownership timeline and the litigation context.

TradeStation Technologies, Inc. (formerly Omega Research, Inc., founded 1982) is the technology and intellectual-property subsidiary of TradeStation Group, Inc., headquartered in Plantation, Florida, with additional offices in Richardson, Texas. TradeStation Group was Nasdaq-listed (TRAD) until June 2011, when Monex Group, Inc. (Tokyo Stock Exchange: 8698) acquired it for roughly $402 million and delisted it. TradeStation Technologies is therefore a subsidiary of a Japanese public parent. Entity-level headcount and revenue are not disclosed; third-party estimates for the TradeStation group range widely (roughly 500–1,400 employees; ~$100M–$400M revenue) and are unverified.

Products / services. TradeStation Technologies develops and licenses strategy-trading software and subscription tools and owns the group's intellectual property. The wider group operates the multi-asset TradeStation electronic trading platform for equities, options, futures and forex, offering order execution, market scanning, strategy back-testing and automation via its EasyLanguage language. Brokerage/execution sits in TradeStation Securities, Inc. (a self-clearing broker-dealer and futures commission merchant), TradeStation Forex, Inc. and TradeStation Prime Services, Inc.; portfolio-testing software Portfolio Maestro was acquired from RINA Technologies in 2010. TradeStation 9.5 is a named platform version.

Patent-litigation posture. This is an operating company, overwhelmingly on the defensive side of NPE suits. Of four tracked matters, one is a defense: Chart Trading Development, LLC v. TradeStation Group, Inc. et al., filed December 3, 2015 in the plaintiff-friendly Eastern District of Texas, Tyler Division. The other three are PTAB covered-business-method petitions in which TradeStation appears as a co-petitioner alongside other brokers, not as a standalone filer.

Notable cases/context. CTD — described in filings as a non-practicing entity — asserted trading-interface patents (the '611, '190, '416, '626 and '435 patents) against roughly 32 defendants, accusing the TradeStation 9.5 platform. TradeStation joined CQG and Interactive Brokers in 2016 CBM petitions; the district court stayed the Texas case pending CBM review. Defendants argued CTD was created to insulate its corporate owner, the BGC Group, from discovery.

Watchlist

Get alerted when TradeStation Technologies, Inc. sues again.

Email-only, free, anonymous. We'll notify you when TradeStation Technologies, Inc. files another patent-infringement lawsuit. One-click unsubscribe from any alert.

CQG, Inc. et al. v. Chart Trading Development, LLC

final written decision; claims invalidated
Docket:
CBM2016-00046
Filed:
2016-03-18
Terminated:
2017-09-01
Patents:7890416

Covered business method review of U.S. Patent No. 7,890,416 brought by CQG, Inc. and other petitioners against patent owner Chart Trading Development, LLC. The PTAB instituted review on September 13, 2016, and issued a final written decision on September 1, 2017, invalidating the claims.

Interactive Brokers LLC et al. v. Chart Trading Development, LLC

final written decision; all claims unpatentable; affirmed on appeal
Docket:
CBM2016-00038
Filed:
2016-02-19
Terminated:
2017-08-18
Patents:7113190

Covered Business Method review petition challenging all claims of U.S. Patent No. 7,113,190. Instituted August 23, 2016; final written decision August 18, 2017 held all challenged claims unpatentable under 35 U.S.C. § 101 and § 103(a) and denied Patent Owner's motion to amend.

Interactive Brokers LLC et al. v. Chart Trading Development, LLC

final written decision; claims unpatentable
Docket:
CBM2016-00039
Filed:
2016-02-19
Terminated:
2017-08-18
Patents:8380611

Covered business method review of U.S. Patent No. 8,380,611. The Board instituted review of claims 1-22 and issued a Final Written Decision on August 18, 2017, holding all claims unpatentable under 35 U.S.C. §§ 101 and 103(a); the contingent motion to amend was denied.